Laboratory, Myocardial Infarction and Plaque

Safety and possible anti-inflammatory effect of paclitaxel associated with LDL-like nanoparticles (LDE) in patients with chronic coronary artery disease: a double-blind, placebo-controlled pilot study

Frontiers in Cardiovascular Medicine

FEBRUARY 20, 2024

We investigated whether treatment with LDE-paclitaxel changes plaque progression by coronary CT angiography and is safe in patients with chronic coronary artery disease. Clinical and laboratory safety evaluations were made at baseline and every 3 weeks until the end of the study.

Coronary Artery Disease

Coronary Artery Disease Laboratory Plaque Biomarkers

Micro and Nanoplastics and Cardiovascular Events – Recent Study

All About Cardiovascular System and Disorders

MARCH 7, 2024

Detailed analysis of the excised carotid plaques were carried out with pyrolysis-gas chromatography-mass spectrometry, stable isotope analysis, and electron microscopy. Primary endpoint of the study was a composite of myocardial infarction, stroke, or death from any cause in those who had micro and nanoplastics in the carotid plaque.

Plaque

Plaque Myocardial Infarction Laboratory Cardiac Function

Cardiovascular Update

Safety and possible anti-inflammatory effect of paclitaxel associated with LDL-like nanoparticles (LDE) in patients with chronic coronary artery disease: a double-blind, placebo-controlled pilot study

Micro and Nanoplastics and Cardiovascular Events – Recent Study

Stay Connected